Clinical Trial Update: Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation

View source ↗

Summary

This update describes a randomized trial evaluating donor-specific immune (DSI) therapy using HLA-mismatched donors to treat relapse leukemia after HLA-matched …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• HLA-mismatched DSI

Snippet

Sponsor: huishengai | Conditions: Relapse Leukemia | Status: COMPLETED